CX Partners is investing upto R200Cr in Bangalore based Sutures India for a 40% stake. According to ToI,CX Partners will buyout Evolvence Life Sciences Fund's stake and may also buy part of the promoter's stake in the company. The deal is subject to FIPB approval.
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.